155 related articles for article (PubMed ID: 20015915)
1. Clinical associations with autoantibody reactivities to individual components of U1 small nuclear ribonucleoprotein.
Kaneko Y; Suwa A; Hirakata M; Ikeda Y; Kuwana M
Lupus; 2010 Mar; 19(3):307-12. PubMed ID: 20015915
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
[TBL] [Abstract][Full Text] [Related]
3. Anti-(U1) small nuclear RNA antibodies in anti-small nuclear ribonucleoprotein sera from patients with connective tissue diseases.
van Venrooij WJ; Hoet R; Castrop J; Hageman B; Mattaj IW; van de Putte LB
J Clin Invest; 1990 Dec; 86(6):2154-60. PubMed ID: 1701452
[TBL] [Abstract][Full Text] [Related]
4. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease.
Murakami A; Kojima K; Ohya K; Imamura K; Takasaki Y
Arthritis Rheum; 2002 Dec; 46(12):3273-82. PubMed ID: 12483732
[TBL] [Abstract][Full Text] [Related]
5. Human anti-nuclear ribonucleoprotein antigen autoimmune sera contain a novel subset of autoantibodies that stabilizes the molecular interaction of U1RNP-C protein with the Sm core proteins.
Satoh M; Richards HB; Hamilton KJ; Reeves WH
J Immunol; 1997 May; 158(10):5017-25. PubMed ID: 9144522
[TBL] [Abstract][Full Text] [Related]
6. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.
Fatenejad S; Brooks W; Schwartz A; Craft J
J Immunol; 1994 Jun; 152(11):5523-31. PubMed ID: 7514640
[TBL] [Abstract][Full Text] [Related]
7. Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoantibodies as well as with experimentally-induced mouse monoclonal antibodies.
Habets WJ; Hoet MH; De Jong BA; Van der Kemp A; Van Venrooij WJ
J Immunol; 1989 Oct; 143(8):2560-6. PubMed ID: 2477448
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
Hof D; Raats JM; Pruijn GJ
Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody production against the U small nuclear ribonucleoprotein particle proteins E, F and G in patients with connective tissue diseases.
Reuter R; Rothe S; Habets W; Van Venrooij WJ; Lührmann R
Eur J Immunol; 1990 Feb; 20(2):437-40. PubMed ID: 2138085
[TBL] [Abstract][Full Text] [Related]
10. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
11. Human anti-RNP sera contain both human-specific and cross-reactive anti-70K autoantibodies.
Henriksson EW; Pettersson I
J Autoimmun; 1996 Aug; 9(4):551-9. PubMed ID: 8864832
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of antibodies to TS1-RNA in patients with mixed connective tissue disease.
Ikeda K; Takasaki Y; Hirokawa K; Takeuchi K; Hashimoto H
J Rheumatol; 2003 May; 30(5):998-1005. PubMed ID: 12734895
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
14. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
[TBL] [Abstract][Full Text] [Related]
15. Close association of anti-U1 ribonucleoprotein antibody with drug allergy in patients with connective tissue diseases.
Ashida R; Asano Y; Tamaki Z; Tomita M; Kawashima T; Aakamata K; Sato S
J Dermatol Sci; 2010 Oct; 60(1):56-7. PubMed ID: 20837391
[No Abstract] [Full Text] [Related]
16. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
Margaux J; Hayem G; Palazzo E; Chazerain P; De Bandt M; Haim T; Kahn MF; Meyer O
Rev Rhum Engl Ed; 1998 Jun; 65(6):378-86. PubMed ID: 9670329
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anti-U1 RNA antibodies in patients with connective tissue disease. Association with HLA and clinical manifestations of disease.
Hoffman RW; Sharp GC; Deutscher SL
Arthritis Rheum; 1995 Dec; 38(12):1837-44. PubMed ID: 8849357
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
Combe B; Rucheton M; Graafland H; Lussiez V; Brunel C; Sany J
Clin Exp Immunol; 1989 Jan; 75(1):18-24. PubMed ID: 2702772
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal autoantibody recognizing a unique set of small nuclear ribonucleoprotein complexes.
Winkler A; Watson-McKown R; Wise KS
J Immunol; 1988 Jan; 140(1):69-77. PubMed ID: 2447172
[TBL] [Abstract][Full Text] [Related]
20. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule.
Degen WG; Aarssen Y; Pruijn GJ; Utz PJ; van Venrooij WJ
Cell Death Differ; 2000 Jan; 7(1):70-9. PubMed ID: 10713722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
